Why is uniQure Stock (QURE) Down Nearly 60% Today?
Shares in gene therapy company uniQure ($QURE) plunged in pre-market trading today after it revealed that the effectiveness of its Huntington’s dis...
Uniqure N.v. (QURE)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Seas Capital Sina Toussi | 1,324,022 | $31,988,372 | -9% | 0.37% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $45.89 | 7,600 | $348,764.00 | 519,227 | 2026-07-02 | Filing | |
| $45.43 | 4,282 | $194,531.26 | 526,827 | 2026-07-02 | Filing | |
| $44.43 | 9,200 | $408,756.00 | 531,109 | 2026-07-02 | Filing | |
| $46.40 | 20,000 | $928,000.00 | 148,235 | 2026-06-30 | Filing | |
| $46.46 | 10,000 | $464,600.00 | 168,235 | 2026-06-30 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 766 | $18,507 | 0% | |
| 2. | 96 | $2,319 | 0% | |
| 3. | 85 | $2,054 | 0% | |
| 4. | 60 | $1,450 | 0% | |
| 5. | 19 | $459 | 0% |
News See All
uniQure (QURE) Submitted AMT-130 for Accelerated Approval in Huntington’s Disease. Can Externally Controlled Data Support the Application?
uniQure N.V. (NASDAQ:QURE) submitted a biologics license application, or BLA, to the U.S.
UniQure N.V. (QURE) Upgraded to Overweight as Huntington’s Disease Program Advances
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. UniQure N.V. (NASDAQ:QURE) is among the best healthcare stocks.
10 Best Healthcare Stocks to Buy According to Wall Street Analysts
In this article, we will be taking a look at the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. The U.S.
10 Stocks Making Investor Richer
Ten stocks stood firmer on Wednesday, defying a lackluster performance on Wall Street, thanks to a combination of macroeconomic and corporate developments that bolstered buying appetite.
10 Best Gene Therapy Stocks to Buy in 2026
In this article, we will discuss the 10 Best Gene Therapy Stocks to Buy in 2026.
Is uniQure N.V. (QURE) A Good Stock To Buy Now?
Is QURE a good stock to buy? We came across a bullish thesis on uniQure N.V. on r/stocks by AntoniaFauci. In this article, we will summarize the bulls’ thesis on QURE.
10 Best Small-Cap Biotech Stocks to Buy According to Hedge Funds
In this article, we will look at the 10 Best Small Cap Biotech Stocks to Buy According to Hedge Funds.
7 Best Small-Cap Healthcare Stocks to Buy According to Hedge Funds
In this article, we will look at the best small-cap healthcare stocks to buy according to hedge funds.
uniQure N.V. (NASDAQ:QURE) Q4 2025 Earnings Call Transcript
uniQure N.V. (NASDAQ:QURE) Q4 2025 Earnings Call Transcript March 2, 2026uniQure N.V. beats earnings expectations. Reported EPS is $-0.64495, expectations were $-0.93.
Hedge Fund Resource Center